Holocene Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,463
Closed -$465K 840
2025
Q4
$465K Sell
11,463
-30,529
-73% -$1.33M ﹤0.01% 674
2025
Q3
$1.97M Sell
41,992
-8,378
-17% -$434K ﹤0.01% 534
2025
Q2
$2.62M Buy
50,370
+18,894
+60% +$1.04M 0.01% 523
2025
Q1
$1.9M Buy
+31,476
New +$2.03M 0.01% 547
2023
Q1
Sell
-53,053
Closed -$4.7M 736
2022
Q4
$4.7M Buy
53,053
+30,991
+140% +$2.57M 0.03% 295
2022
Q3
$1.77M Buy
+22,062
New +$2.08M 0.01% 465
2020
Q4
Sell
-6,922
Closed -$545K 759
2020
Q3
$545K Buy
6,922
+3,407
+97% +$278K ﹤0.01% 565
2020
Q2
$253K Sell
3,515
-2,948
-46% -$205K ﹤0.01% 577
2020
Q1
$370K Buy
6,463
+2,074
+47% +$191K ﹤0.01% 589
2019
Q4
$491K Sell
4,389
-817
-16% -$87.1K ﹤0.01% 628
2019
Q3
$501K Sell
5,206
-3,029
-37% -$284K 0.01% 591
2019
Q2
$705K Sell
8,235
-1,812
-18% -$149K 0.01% 377
2019
Q1
$836K Sell
10,047
-2,586
-20% -$188K 0.01% 292
2018
Q4
$811K Buy
12,633
+5,600
+80% +$383K 0.01% 303
2018
Q3
$557K Buy
+7,033
New +$544K 0.01% 516

Other funds holding CNMD

Holocene Advisors's CNMD Position: Q1 2026 in Review

Holocene Advisors sold out of CONMED (CNMD) in Q1 2026, closing a stake of 11,463 shares — an estimated $465K sold.

Holocene Advisors first reported a position in CNMD in Q3 2018 and held it in 15 quarters. The position peaked at $4.7M in Q4 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Holocene Advisors reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 11,463 CONMED shares in Q1 2026, an estimated $465K.
  • Holocene Advisors first reported a position in CONMED in Q3 2018 and held it in 15 quarters.
  • Holocene Advisors's CONMED position peaked at $4.7M in Q4 2022.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.